Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
Study sponsor: Cardiff Oncology
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-10-16Actual
Enrollment · participants72Actual
Source updated2024-11-07Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.